Transient receptor potential vanilloid 4 channels as therapeutic targets in diabetes and diabetes‐related complications
Abstract With an estimated 425 million diabetes patients worldwide in 2019, type 2 diabetes has reached a pandemic proportion and represents a major unmet medical need. A key determinant of the development and progression of type 2 diabetes is pancreatic ‐cell dysfunction, including the loss of cell...
Main Authors: | Wei Hu, Yuanlin Ding, Qingqing Li, Rou shi, Yuqing He |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-07-01
|
Series: | Journal of Diabetes Investigation |
Subjects: | |
Online Access: | https://doi.org/10.1111/jdi.13244 |
Similar Items
-
Transient receptor potential vanilloid type 1: cardioprotective effects in diabetic models
by: Jiaqi Bao, et al.
Published: (2023-12-01) -
Activation of Transient Receptor Potential Vanilloid-3 Channels in Keratinocytes Induces Pruritus in Humans
by: Jin Cheol Kim, et al.
Published: (2021-08-01) -
Lymphangiogenesis and angiogenesis rescue murine ischemic hindlimb via transient receptor potential vanilloid 4
by: Hideaki Yamada, et al.
Published: (2021-08-01) -
Transient receptor potential vanilloid-1 (TRPV1) channels act as suppressors of the growth of glioma
by: Jingjing Cheng, et al.
Published: (2024-06-01) -
Transient receptor potential vanilloid subtype 1: A potential therapeutic target for fibrotic diseases
by: Guangxin Peng, et al.
Published: (2022-08-01)